🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

1 Tablet(s) Serving Size
90 Servings
Other Combinations Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Proprietary Blend
325 mg
Proprietary Tri-Xanthine(TM) Blend
375 mg

Other Ingredients

Dextrose Microcrystalline Cellulose Hydroxypropyl Methylcellulose Stearic Acid Magnesium Stearate Sodium Starch Glucolate Starch Triacetin Titanium Dioxide Silica FD&C Blue #1 FD&C Red #40

Label Claims — Verification

All Other
Structure/Function

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Dosage: Take 1-2 tablets in the morning and 1 tablet after lunch. Do not exceed 4 tablets daily.

⚠️ Warnings & Precautions

DO NOT CONSUME SYNEPHRINE OR CAFFEINE FROM OTHER SOURCES, INCLUDING BUT NOT LIMITED TO, COFFEE, TEA, SODA AND OTHER DIETARY SUPPLEMENTS OR MEDICATIONS CONTAINING PHENYLEPHRINE OR (WARNINGS/INFORMATION CONTINUED ON BACK OF LABEL)

SALE TO PERSONS 17 YEARS OF AGE OR YOUNGER IS PROHIBITED

Tamper Evident Do Not Use If Printed Seal Is Cut, Torn Or Missing

CONSULT WITH YOUR PHYSICIAN PRIOR TO USE IF YOU ARE PREGNANT OR NURSING, OR IF YOU ARE TAKING MEDICATION, INCLUDING BUT NOT LIMITED TO MAOI INHIBITORS, ANTIDEPRESSANTS, ASPIRIN, NONSTEROODAL ANTI-INFLAMATORY DRUGS OR PRODUCTS CONTAINING PHYLEPHRINE, EPHEDRINE, PSEUDOEPHEDRINE, OR OTHER STIMULANTS.

CONSULT YOUR PHYSICIAN PRIOR TO USE IF YOU HAVE A MEDICAL CONDITION, INCLUDING BUT NOT LIMITED TO, HEART, LIVER, KIDNEY, OR THYROID DISEASE, PSYCHIATRIC OR EPILEPTIC DISORDERS, DIFFICULTY URINATING, DIABETES, HIGH BLOOD PRESSURE, CARDIAC ARRHYTHMIA, RECURRENT HEADACHES, ENLARGED PROSTATE OR GLAUCOMA. DISCONTINUE 2 WEEKS PRIOR TO SURGERY OR IF YOU EXPERIENCE RAPID HEART BEAT, DIZZINESS, SEVERE HEADACHE OR SHORTNESS OF BREATH. IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY. AVOID ALCOHOL WHILE TAKING THIS PRODUCT. DO NOT EXCEED RECOMMENDED SERVING. EXCEEDING RECOMMENDED SERVING MAY CAUSE SERIOUS ADVERSE HEALTH EFFECTS, INCLUDING HEART ATTACK AND STROKE. DISCONTINUE USE AND CALL A PHYSICIAN OR LICENSED HEALTH CARE PROFESSIONAL IMMEDIATELY IF YOU EXPERIENCE RAPID HEARTBEAT, DIZZINESS, SEVER HEADACHE, SHORTNESS OF BREATH, OR OTHER SIMILAR SYMPTOMS. IMPROPER USE OF THIS PRODUCT MAY BE HAZARDOUS TO A PERSON'S HEALTH. EXCEEDING RECOMMENDED SERVING WILL NOT IMPROVE RESULTS.

WARNING: NOT INTENDED FOR USE BY PERSONS UNDER AGE 18.

DO NOT EXCEED RECOMMENDED DOSE.

{Continued from front panel} CAFFEINE.

DO NOT USE FOR MORE THAN 8 WEEKS.

🧪 Formulation Notes

CONTAINS CAFFEINE.

Additional Information

PEEL HERE

THE WORLD’S MOST ADVANCED WEIGHT LOSS AID EVER DEVELOPED WITH RAPID RELEASE TECHNOLOGY!

EXTREME THERMOGENIC AGENT DEVELOPED TO EVISCERATE FAT!

HI-TECH PHARMACEUTICALS HTP

RAPID RELEASE TABLETS 700MG

To report adverse effects call FDA's MedWatch at 1-800-332-1088.

Product Details

UPC / SKU 8 57084 00096 5
DSLD Entry Date 2013-03-25
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 19839
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.